107 related articles for article (PubMed ID: 7624120)
1. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.
Murrell AM; Bockamp EO; Göttgens B; Chan YS; Cross MA; Heyworth CM; Green AR
Oncogene; 1995 Jul; 11(1):131-9. PubMed ID: 7624120
[TBL] [Abstract][Full Text] [Related]
2. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain.
Green AR; Lints T; Visvader J; Harvey R; Begley CG
Oncogene; 1992 Apr; 7(4):653-60. PubMed ID: 1565464
[TBL] [Abstract][Full Text] [Related]
3. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
4. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
5. Erythroid expression of the 'helix-loop-helix' gene, SCL.
Green AR; Salvaris E; Begley CG
Oncogene; 1991 Mar; 6(3):475-9. PubMed ID: 2011404
[TBL] [Abstract][Full Text] [Related]
6. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
7. SCL and related hemopoietic helix-loop-helix transcription factors.
Green AR; Begley CG
Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
9. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
10. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6.
Begley CG
Stem Cells; 1994; 12 Suppl 1():143-9; discussion 149-51. PubMed ID: 7696958
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
Visvader J; Begley CG; Adams JM
Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
[TBL] [Abstract][Full Text] [Related]
12. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
Shivdasani RA; Mayer EL; Orkin SH
Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
[TBL] [Abstract][Full Text] [Related]
13. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
15. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
[TBL] [Abstract][Full Text] [Related]
17. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
18. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.
Giroux S; Kaushik AL; Capron C; Jalil A; Kelaidi C; Sablitzky F; Dumenil D; Albagli O; Godin I
Gene Expr Patterns; 2007 Jan; 7(3):215-26. PubMed ID: 17112790
[TBL] [Abstract][Full Text] [Related]
19. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
20. Erythroid Krüppel-like factor exhibits an early and sequentially localized pattern of expression during mammalian erythroid ontogeny.
Southwood CM; Downs KM; Bieker JJ
Dev Dyn; 1996 Jul; 206(3):248-59. PubMed ID: 8896981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
